| Name | LARGE xylosyl- and glucuronyltransferase 1 |
| Description | This gene encodes a member of the N-acetylglucosaminyltransferase gene family. It encodes a glycosyltransferase which participates in glycosylation of alpha-dystroglycan, and may carry out the synthesis of glycoprotein and glycosphingolipid sugar chains. It may also be involved in the addition of a repeated disaccharide unit. The protein encoded by this gene is the glycotransferase that adds the final xylose and glucuronic acid to alpha-dystroglycan and thereby allows alpha-dystroglycan to bind ligands including laminin 211 and neurexin. Mutations in this gene cause several forms of congenital muscular dystrophy characterized by cognitive disability and abnormal glycosylation of alpha-dystroglycan. Alternative splicing of this gene results in multiple transcript variants that encode the same protein. [provided by RefSeq, May 2018] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n LARGE1 is a bifunctional glycosyltransferase that catalyzes the final steps in the post‐translational modification of α‑dystroglycan (α‑DG). In this role, LARGE1 transfers xylose and glucuronic acid from their UDP‐activated donors to form a repeating disaccharide polymer (matriglycan) on a primed O‑mannosyl glycan of α‑DG, which is essential for high‐affinity binding to extracellular matrix ligands such as laminin."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": " LARGE1’s activity is dependent on prior steps of O‑mannosyl glycosylation (for example, mediated by POMT2) and, in so doing, it effectively endows α‑DG with its receptor function that is critical for basement membrane assembly and cell–matrix interactions."}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Disruption of LARGE1 function via mutations or misregulation results in underglycosylation of α‑DG, which is implicated in a spectrum of dystroglycanopathies characterized by muscular dystrophy and central nervous system abnormalities."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}, {"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": " In addition, studies in malignant contexts have revealed that LARGE1 expression levels correlate with tumor cell behavior; for instance, downregulation of LARGE1 is associated with loss of matriglycan and impaired laminin binding in rhabdomyosarcoma, while upregulation in liver cancer cells appears to promote cell proliferation, migration, and invasion, and copy number alterations involving LARGE1 have been observed in glioblastoma."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "5", "end_ref": "7"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Moreover, the extent of matriglycan polymerization by LARGE1 can be modulated by competing enzymes such as HNK‑1 sulfotransferase, which caps the terminal glucuronic acid residue, thereby regulating polymer length in a tissue‐specific manner."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": " Collectively, these findings underscore the central role of LARGE1 in both maintaining normal tissue integrity through proper α‑DG glycosylation and contributing to disease pathogenesis when its function is compromised or aberrantly regulated.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Tobias Willer, Kei-Ichiro Inamori, David Venzke, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated α-dystroglycan functional glycosylation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Elife (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7554/eLife.03941"}], "href": "https://doi.org/10.7554/eLife.03941"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25279699"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25279699"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Peng Zhang, Huaiyu Hu "}, {"type": "b", "children": [{"type": "t", "text": "Differential glycosylation of α-dystroglycan and proteins other than α-dystroglycan by like-glycosyltransferase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Glycobiology (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/glycob/cwr131"}], "href": "https://doi.org/10.1093/glycob/cwr131"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21930648"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21930648"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Kei-Ichiro Inamori, Aaron M Beedle, Daniel Beltrán-Valero de Bernabé, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LARGE2-dependent glycosylation confers laminin-binding ability on proteoglycans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Glycobiology (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/glycob/cww075"}], "href": "https://doi.org/10.1093/glycob/cww075"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27496765"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27496765"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Benedetta Righino, Manuela Bozzi, Davide Pirolli, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification and Modeling of a GT-A Fold in the α-Dystroglycan Glycosylating Enzyme LARGE1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Chem Inf Model (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/acs.jcim.0c00281"}], "href": "https://doi.org/10.1021/acs.jcim.0c00281"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32356985"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32356985"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Daniel Beltrán, Mary E Anderson, Narendra Bharathy, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Skelet Muscle (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13395-019-0195-0"}], "href": "https://doi.org/10.1186/s13395-019-0195-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31054580"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31054580"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Min Wang, Haiyan Tao, Ping Huang "}, {"type": "b", "children": [{"type": "t", "text": "Clinical significance of LARGE1 in progression of liver cancer and the underlying mechanism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2021.145493"}], "href": "https://doi.org/10.1016/j.gene.2021.145493"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33588034"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33588034"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Lisandra Muñoz-Hidalgo, Teresa San-Miguel, Javier Megías, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Somatic copy number alterations are associated with EGFR amplification and shortened survival in patients with primary glioblastoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neoplasia (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neo.2019.09.001"}], "href": "https://doi.org/10.1016/j.neo.2019.09.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31751860"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31751860"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "M Osman Sheikh, David Venzke, Mary E Anderson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HNK-1 sulfotransferase modulates α-dystroglycan glycosylation by 3-O-sulfation of glucuronic acid on matriglycan."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Glycobiology (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/glycob/cwaa024"}], "href": "https://doi.org/10.1093/glycob/cwaa024"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32149355"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32149355"}]}]}]}
|
| NCBI Gene ID | 9215 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
LARGE1 has 3,733 functional associations with biological entities spanning 6 categories (chemical, disease, phenotype or trait, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 33 datasets.
Click the + buttons to view associations for LARGE1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of LARGE1 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of LARGE1 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with LARGE1 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with LARGE1 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of LARGE1 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing LARGE1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with LARGE1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving LARGE1 gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with LARGE1 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with LARGE1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving LARGE1 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing LARGE1 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by LARGE1 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of LARGE1 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of LARGE1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of LARGE1 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with LARGE1 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of LARGE1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of LARGE1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| KEGG Pathways 2026 | pathways involving LARGE1 protein from the KEGG Pathways 2026 dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of LARGE1 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of LARGE1 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of LARGE1 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving LARGE1 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2024 | pathways involving LARGE1 protein from the Reactome Pathways 2024 dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of LARGE1 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of LARGE1 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of LARGE1 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of LARGE1 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of LARGE1 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of LARGE1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of LARGE1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with LARGE1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |